LKFT Lakefront Biotherapeutics NV - ADR

$29.37
$0.51
(1.77%)
Today
Closed $29.37
$0.00
(0.00%)
After Hours
55

Bullish Sentiment

How do you feel about LKFT?

Loading...
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.read more...
Benzinga
This Editas Medicine Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded Microsoft, Graphic Packaging, Editas Medicine and Lakefront Biotherapeutics, with mixed price-target changes.read more...
Benzinga
Keymed Biosciences Announces 2026 H1 Results and Business Updates
Keymed Biosciences Announces 2026 H1 Results and Business Updates Keymed Biosciences Announces 2026 H1 Results and Business Updates PR Newswire CHENGDU, China, Aug. 20, 2026 CHENGDU, China, Aug. 20, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim...
PR Newswire
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Gilead Sciences, Inc. (Nasdaq: GILD) and Lakefront Biotherapeutics NV (Euronext & Nasdaq: LKFT) today announced the successful completion of the previously announced acquisition of Ouro Medicines to advance T cell engager therapies for autoimmune diseases. This press release features multimedia...
Business Wire